Sökning: WFRF:(Glimelius Bengt) > Autoimmune and Atop...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05138naa a2200601 4500 | |
001 | oai:DiVA.org:uu-264812 | |
003 | SwePub | |
008 | 151019s2015 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:132036118 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2648122 URI |
024 | 7 | a https://doi.org/10.1093/aje/kwv0812 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1320361182 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hollander, Peteru Uppsala universitet,Klinisk och experimentell patologi,Rose-Marie Amini4 aut0 (Swepub:uu)petho189 |
245 | 1 0 | a Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma |
264 | c 2015-09-06 | |
264 | 1 | b Oxford University Press (OUP),c 2015 |
338 | a print2 rdacarrier | |
520 | a Results from previous investigations have shown associations between the risk of Hodgkin lymphoma (HL) and a history of autoimmune and atopic diseases, but it remains unknown whether these associations apply to all types of HL or only to specific subtypes. We investigated immune diseases and the risk of classical HL in a population-based case-control study that included 585 patients and 3,187 controls recruited from October 1999 through August 2002. We collected information on immune diseases through telephone interviews and performed serological analyses of specific immunoglobulin E reactivity. Tumor Epstein-Barr virus (EBV) status was determined for 498 patients. Odds ratios with 95% confidence intervals were calculated using logistic regression analysis. Rheumatoid arthritis was associated with a higher risk of HL (odds ratio (OR) = 2.63; 95% confidence interval (CI): 1.47, 4.70), especially EBV-positive HL (OR = 3.18; 95% CI: 1.23, 8.17), and with mixed-cellularity HL (OR = 4.25; 95% CI: 1.66, 10.90). HL risk was higher when we used proxies of severe rheumatoid arthritis, such as ever having received daily rheumatoid arthritis medication (OR = 3.98; 95% CI: 2.08, 7.62), rheumatoid arthritis duration of 6-20 years (OR = 3.80; 95% CI: 1.72, 8.41), or ever having been hospitalized for rheumatoid arthritis (OR = 7.36; 95% CI: 2.95, 18.38). Atopic diseases were not associated with the risk of HL. EBV replication induced by chronic inflammation in patients with autoimmune diseases might explain the higher risk of EBV-positive HL. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Arbetsmedicin och miljömedicin0 (SwePub)303032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Occupational Health and Environmental Health0 (SwePub)303032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Klinisk laboratoriemedicin0 (SwePub)302232 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Clinical Laboratory Medicine0 (SwePub)302232 hsv//eng |
653 | a atopic hypersensitivity | |
653 | a Epstein-Barr virus | |
653 | a Hodgkin lymphoma | |
653 | a primary Sjogren's syndrome | |
653 | a rheumatoid arthritis | |
653 | a systemic lupus erythematosus | |
653 | a Pathology | |
653 | a Patologi | |
700 | 1 | a Rostgaard, Klausu Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.4 aut |
700 | 1 | a Smedby, Karin E.u Karolinska Institutet4 aut |
700 | 1 | a Chang, Ellen T.u Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA.;Exponent Inc, Hlth Sci, Menlo Pk, CA USA.4 aut |
700 | 1 | a Amini, Rose-Marieu Uppsala universitet,Klinisk och experimentell patologi,Rose-Marie Amini4 aut0 (Swepub:uu)roseamin |
700 | 1 | a Brown, Peter de Nullyu Rigshosp, Dept Haematol, DK-2100 Copenhagen, Denmark.4 aut |
700 | 1 | a Glimelius, Bengtu Uppsala universitet,Experimentell och klinisk onkologi4 aut0 (Swepub:uu)bengglim |
700 | 1 | a Adami, Hans-Olovu Karolinska Institutet4 aut |
700 | 1 | a Melbye, Madsu Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.4 aut |
700 | 1 | a Glimelius, Ingridu Karolinska Institutet,Uppsala universitet,Experimentell och klinisk onkologi4 aut0 (Swepub:uu)inggl846 |
700 | 1 | a Hjalgrim, Henriku Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.4 aut |
710 | 2 | a Uppsala universitetb Klinisk och experimentell patologi4 org |
773 | 0 | t American Journal of Epidemiologyd : Oxford University Press (OUP)g 182:7, s. 624-632q 182:7<624-632x 0002-9262x 1476-6256 |
856 | 4 | u https://academic.oup.com/aje/article-pdf/182/7/624/250746/kwv081.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-264812 |
856 | 4 8 | u https://doi.org/10.1093/aje/kwv081 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:132036118 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.